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The rate of nasal carriage of Staphylococcus aureus and as-
sociated risk factors were determined in a cross-sectional
study involving Swiss children’s hospitals. S. aureus was iso-
lated in 562 of 1363 cases. In a stepwise multivariate analysis,
the variables age, duration of antibiotic use, and hospitali-
zation of a household member were independently associated
with carriage of S. aureus.
Staphylococcus aureus is an important pathogen that causes
community-associated and health care–associated infections in
all age groups [1, 2]. It colonizes the skin and mucosa of hu-
mans, and subsequent infections affect virtually all organ
systems.
Several studies have aimed to determine the prevalence and
risk factors for nasal S. aureus colonization in children and
have had variable results [3–8]. We aimed to determine the
prevalence of and risk factors for nasal S. aureus colonization
in children requiring hospitalization.
Patients and methods. Methodological details of this mul-
ticenter, cross-sectional study involving children admitted to 9
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large training hospitals in Switzerland from 16 March through
15 April 2006 have been published previously [9]. A nasal swab
sample from both nostrils was collected for culture of S. aureus
within 48 h after hospital admission, and the following com-
prehensive patient characteristics were obtained: date of hos-
pital admission, date of birth, sex, reason for hospitalization,
chronic underlying disease, pets in the household, history of
travel abroad, hospitalizations in the previous 3 months, an-
tibiotic use (including drug, dosage, and duration) in the pre-
ceding 3 months, previous colonization with methicillin-resis-
tant S. aureus (MRSA), previous hospitalization or current
employment of a family member in a medical institution, and
occurrence of nosocomial S. aureus infection during this
hospitalization.
Data were processed and analyzed by 3 of the investigators
(F.D., T.E., and U.H.). Patients with a culture positive for S.
aureus comprised the methicillin-susceptible S. aureus (MSSA)
carriage group, and patients without a culture positive for S.
aureus comprised the control group. Statistical analyses were
performed with SAS software, version 9.1 (SAS Institute). Po-
tential predictors of colonization with S. aureus were analyzed
with a stepwise regression technique using logistic procedures
in SAS. Independent variables were entered into the model
when the associated P value was !.3 and were retained if the
P value remained !.12. was considered to be statisticallyP ! .05
significant.
Results. There were 1762 hospitalizations involving 1736
eligible children during the study period. A total of 356 hos-
pitalizations (20.2%) were excluded because of parental refusal
(88 hospitalizations); 148 h since hospital admission (72); and
various other reasons, such as hospital discharge before the
investigator could enroll the patient, language barriers, or ab-
sence of parents (196). An additional 43 patients from 1 study
site were excluded because of significant protocol violations.
Thus, nasal swab samples were available from 1363 hospitali-
zations involving 1350 patients.
S. aureus was isolated in 562 cases (41.2%); in 561 of these
cases, only MSSA was isolated, and 1 patient carried both MSSA
and MRSA. Prevalence of nasal colonization with S. aureus
varied between study sites (range, 36.5%–48.0%). Of the 13
patients (1%) who were hospitalized twice, 6 had negative cul-
ture results at both hospitalizations, 4 had cultures that were
positive for S. aureus at both hospitalizations, and 3 had neg-
ative culture results during the first hospitalization and culture
results that were positive for S. aureus during the second hos-
pitalization. Of 1363 hospitalizations, 906 (66.5%) involved
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Male 732/1361 53.8 (51.4–56.7) 319/732 43.6 (40.0–47.2) 1.23 (0.98–1.54) .067
Female 629/1361 46.2 (43.4–48.7) 243/629 38.6 (34.8–42.4) …
Swiss nationality 906/1348 67.2 (64.5–69.5) 370/906 40.8 (37.6–44.0) 0.93 (0.73–1.17) .54
Chronic underlying disease 321/1346 23.8 (21.7–26.3) 124/321 38.6 (33.3–44.0) 0.87 (0.66–1.12) .278
Presence of a pet in the household 571/1362 41.9 (39.4–44.6) 248/571 43.4 (39.4–47.5) 1.22 (0.97–1.52) .081
Previous stay abroad 224/1363 16.4 (14.1–18.0) 80/224 35.7 (29.4–42.0) 0.77 (0.57–1.05) .103
Duration of previous antibiotic use
1–6 days 115/1359 8.5 (6.9–10.0) 51/115 44.3 (35.3–53.4) 1.04 (0.68–1.49) .98
7 days 255/1359 18.7 (16.7–20.8) 69/255 27.1 (21.6–32.5) 0.45 (0.33–0.62) !.001
Previous hospitalization of family member 178/1350 13.2 (11.2–14.8) 90/178 50.6 (43.2–57.9) 1.56 (1.18–2.15) .007
Current stay at a university hospital 951/1363 69.8 (67.6–72.4) 374/951 39.3 (36.2–42.4) 0.775 (0.61–0.98) .035
Previous hospitalization 260/1360 19.1 (16.9–21.1) 102/260 39.2 (33.3–45.2) 0.89 (0.67–1.18) .44
Family member working in medical institution 232/1362 17.0 (15.0–19.0) 103/232 44.4 (38.0–50.8) 1.17 (0.88–1.56) .286
Patient age, per year … … … … 1.03 (1.01–1.05) .010
Swiss citizens, 442 (32.4%) involved individuals of foreign or-
igin who were living in Switzerland, and 15 involved individuals
whose nationality was unknown.
We compared potential risk factors for colonization and de-
mographic characteristics of 562 colonized patients with those
of patients who were not colonized with S. aureus (table 1).
Multivariate logistic regression analysis revealed that patient age
( ) and hospitalization of a household member duringPp .003
the previous 3 months ( ) were independent predictorsPp .004
for nasal colonization with S. aureus, whereas antibiotic use
during the previous 3 months ( ) was associated with aP ! .001
lack of S. aureus colonization. Male sex, current hospitalization
in a university hospital, and recent stay abroad tended to be
risk factors for MSSA colonization (with P values ranging from
.07 through .08).
Prevalence of colonization with S. aureus was age dependent,
with prevalence peaks among children 1–2 months of age (57%)
and school-age children (up to 65%; ) (figure 1). ThePp .003
likelihood of being colonized with S. aureus increased with
length of previous hospitalization of a household member:
among hospitalizations of children with a household member
who had been hospitalized for 2–4 days, 5–7 days, and 8
days, colonization rates were 23 (41.8%) of 55 hospitalizations
(95% CI, 29.0%–55.0%), 32 (51.6%) of 62 hospitalizations
(95% CI, 39.6%–64.4%), and 18 (62.1%) of 29 hospitalizations
(95% CI, 44.3%–79.7%), respectively ( ).Pp .004
The influence of duration of antibiotic treatment and of the
kind of antibiotics used was further analyzed. Among hospi-
talizations involving 1–3 cumulative days of antibiotic use, 37
(45.7%) of 81 (95% CI, 35.2%–56.9%) involved patients who
were colonized, and this proportion decreased to 38 (38.8%)
of 98 (95% CI, 29.3%–48.7%), 33 (25.6%) of 129 (95% CI,
18.4%–33.6%), and 13 (20.6%) of 63 (95% CI, 10.9%–31.1%)
among hospitalizations involving 4–7 days, 8–21 days, and 121
days of antibiotic use, respectively ( ).P ! .001
Among antibiotics used by patients before hospitalization,
aminopenicillins (used in 45.9% of cases) and trimethoprim-
sulfamethoxazole (16.4%) were most common. When we clas-
sified the different antibiotics according to their expected ef-
fectiveness against S. aureus, 56 (28.1%) of 199 patients (95%
CI, 21.9%–34.4%) treated with an antibiotic with 160% ex-
pected effectiveness were colonized with S. aureus, compared
with 23 (33.3%) of 69 patients (95% CI, 22.2%–44.5%) treated
with an antibiotic with !30% effectiveness ( ). BothPp .415
rates were lower than those for patients without any antibiotic
use within the previous 3 months (colonization rate, 44.9%;
and , respectively).P ! .001 P ! .06
Children hospitalized at the 5 university hospitals had a
higher prevalence of recent antibiotic use, compared with chil-
dren treated at other teaching hospitals (mean prevalence,
32.5% vs. 24.0%; ); this is probably explained by thePp .002
higher proportion of children with chronic underlying diseases
hospitalized at university hospitals, compared with other teach-
ing hospitals (percentage of hospitalized children with chronic
underlying diseases, 27.3% vs. 16.0%; ). No nosocomialP ! .001
S. aureus infections occurred.
Discussion. The finding of a prevalence of 41.2% for nasal
carriage of S. aureus is higher than those previously reported
for children (18.6%–39.2%) [4, 10, 11]. This might be ex-
plained by our highly sensitive culture method, which used a
selective enrichment broth.
After stepwise multivariate analysis, the variables age, du-
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Figure 1. Methicillin-susceptible Staphylococcus aureus colonization rates, by age and sex. Bars, 95% CIs.
ration of antibiotic use, and hospitalization of a household
member during the previous 3 months were independently
related to carriage of S. aureus. In the National Health and
Nutrition Examination Survey (NHANES) for 2001–2002, nasal
MSSA and MRSA colonization prevalence estimates of 36.9%
and 0.6%, respectively, were found in individuals 1–19 years
of age [10]. MSSA colonization prevalence was highest (45%)
among participants who were 6–11 years of age, which is in
accordance with our results, although we found a further prev-
alence peak in young infants (who were not included in the
NHANES survey).
Only a few systematic studies have addressed risk factors for
MRSA and MSSA colonization among children and have had
variable results [3–5, 11]. Breast-feeding, hospitalization,
chronic skin conditions, and a history of indwelling catheter
or other medical devices were found to be associated with S.
aureus carriage in infants in 1 study [5]. We did not investigate
these variables, because our original goal was to specifically
identify risk factors for MRSA carriage. Furthermore, having a
household member who works in a hospital was documented
as a potential risk factor for MRSA colonization [3], and day
care outside of the home and greater numbers of people in the
household were risk factors for MSSA colonization in children
[4]. Again, we did not obtain these variables in our survey and,
therefore, cannot confirm this finding.
Age was identified in earlier studies as a significant risk factor
for MSSA colonization [4, 5, 10, 11]. Based on NHANES data,
an overall prevalence of S. aureus colonization of 32.4% was
estimated, with the highest proportion (40%–50%) of colo-
nization occurring among participants 6–11 years of age [10,
12]. In a study that determined S. aureus carriage among in-
fants, a high carriage rate (40%–50%) during the first 2 months
of life was found [5]. This is in agreement with our finding of
an MSSA carriage peak among infants 1–2 months of age
(57.0%). The reasons for a further peak among children 8–13
years of age (45.1%–65.5%) may be explained by social factors,
such as household size [4] and school attendance.
In some studies, nasal S. aureus colonization was found to
be more frequent in male patients [11, 12]. However, male sex
was not identified as an independent risk factor in our study.
In contrast with previous studies, we identified recent hos-
pitalization of household members as a possible risk factor for
S. aureus carriage in children. Surprisingly, recent hospitali-
zation of the patient was not an independent risk factor for
MSSA carriage, in contrast with the findings of a previous study
[2]. This may be explained by the effect of antibiotic treatment
on MSSA carriage during a previous hospitalization period.
Recent treatment with antibiotics was associated with a lower
rate of nasal S. aureus colonization in this and 2 previously
published studies [4, 11]. Specifically, cumulative treatment de-
creased the likelihood of a child being colonized. The most
frequently reported antibiotics were aminopenicillins and tri-
methoprim-sulfamethoxazole, both of which are commonly ef-
fective against 160% of MSSA isolates and, consequently, re-
duced the likelihood of MSSA colonization. However, because
of the cross-sectional design of our study, it remains to be
determined whether this is a temporary finding and, if so, how
long such protection lasts.
Our study has some limitations. First, most clinical and so-
ciodemographic data obtained were selected on the basis of the
literature regarding MRSA. Therefore, other factors beyond
those that were identified might also be relevant for MSSA
colonization. Second, study participants had been admitted to
the hospital and, therefore, are not necessarily representative
of the general population of children. Furthermore, not all
geographic areas of Switzerland were represented in this study.
However, limited variability of S. aureus carriage rates between
sites makes it unlikely that this introduced a significant bias.
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Third, body sites other than the nose were not examined in
this study. However, most other comparable studies have also
focused on the anterior nares of the nose, which is the most
frequent site of S. aureus carriage, and detection of colonization
of other body sites would have important implications mainly
in the case of MRSA, which did not play a significant role in
our population.
In summary, the findings of this study allow an estimate of
the current prevalence of S. aureus nasal carriage among chil-
dren in our area. In addition, they provide an opportunity to
identify children with an increased or decreased likelihood of
MSSA carriage.
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